Log in to download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 29/01/2026 | Genzyme Corporation | 58468-5030 | AGALSIDASE BETA | 2003-10-10 | 2026-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (5mg/mL) |
